BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Narożna M, Rubiś B. Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy. Int J Mol Sci 2021;22:8663. [PMID: 34445368 DOI: 10.3390/ijms22168663] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Stati G, Amerio P, Nubile M, Sancilio S, Rossi F, Di Pietro R. Concern about the Effectiveness of mRNA Vaccination Technology and Its Long-Term Safety: Potential Interference on miRNA Machinery. Int J Mol Sci 2023;24. [PMID: 36674919 DOI: 10.3390/ijms24021404] [Reference Citation Analysis]
2 Gambardella J, Kansakar U, Sardu C, Messina V, Jankauskas SS, Marfella R, Maggi P, Wang X, Mone P, Paolisso G, Sorriento D, Santulli G. Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19. J Pharmacol Exp Ther 2023;384:109-15. [PMID: 35772782 DOI: 10.1124/jpet.122.001209] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
3 Gaytán-Pacheco N, Ibáñez-Salazar A, Herrera-Van Oostdam AS, Oropeza-Valdez JJ, Magaña-Aquino M, Adrián López J, Monárrez-Espino J, López-Hernández Y. miR-146a, miR-221, and miR-155 are Involved in Inflammatory Immune Response in Severe COVID-19 Patients. Diagnostics (Basel) 2022;13. [PMID: 36611425 DOI: 10.3390/diagnostics13010133] [Reference Citation Analysis]
4 Roustai Geraylow K, Hemmati R, Kadkhoda S, Ghafouri-fard S. miRNA expression in COVID-19. Gene Reports 2022;28:101641. [DOI: 10.1016/j.genrep.2022.101641] [Reference Citation Analysis]
5 Calderon-dominguez M, Trejo-gutierrez E, González-rovira A, Beltrán-camacho L, Rojas-torres M, Eslava-alcón S, Sanchez-morillo D, Calderon-dominguez J, Martinez-nicolás MP, Gonzalez-beitia E, Nieto-martín MD, Trujillo-soto T, Rodríguez-iglesias MA, Moreno JA, Moreno-luna R, Durán-ruiz MC. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients. Molecular Therapy - Nucleic Acids 2022;29:76-87. [DOI: 10.1016/j.omtn.2022.06.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kubiak JZ, Kloc M. Dissecting Physiopathology of COVID-19. IJMS 2022;23:9602. [DOI: 10.3390/ijms23179602] [Reference Citation Analysis]
7 Hill JM, Lukiw WJ. microRNA, the Innate-Immune System and SARS-CoV-2. Front Cell Infect Microbiol 2022;12:887800. [DOI: 10.3389/fcimb.2022.887800] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 de las Heras JI, Todorow V, Krečinić-balić L, Hintze S, Czapiewski R, Webb S, Schoser B, Meinke P, Schirmer EC. Metabolic, Fibrotic, and Splicing Pathways Are All Altered in Emery-Dreifuss Muscular Dystrophy Spectrum Patients to Differing Degrees.. [DOI: 10.1101/2022.05.20.492778] [Reference Citation Analysis]
9 Yang S, Tong Y, Chen L, Yu W. Human Identical Sequences, hyaluronan, and hymecromone ─ the new mechanism and management of COVID-19. Mol Biomed 2022;3:15. [PMID: 35593963 DOI: 10.1186/s43556-022-00077-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Abusalah MAH, Khalifa M, Al-hatamleh MAI, Jarrar M, Mohamud R, Chan YY. Nucleic Acid-Based COVID-19 Therapy Targeting Cytokine Storms: Strategies to Quell the Storm. JPM 2022;12:386. [DOI: 10.3390/jpm12030386] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Maranini B, Ciancio G, Ferracin M, Cultrera R, Negrini M, Sabbioni S, Govoni M. microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review. Life 2022;12:288. [DOI: 10.3390/life12020288] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
12 Fernández-Pato A, Virseda-Berdices A, Resino S, Ryan P, Martínez-González O, Peréz-García F, Martin-Vicente M, Valle-Millares D, Brochado-Kith O, Blancas R, Martínez A, Ceballos FC, Bartolome-Sánchez S, Vidal-Alcántara EJ, Alonso D, Blanca-López N, Martinez-Acitores IR, Martin-Pedraza L, Jiménez-Sousa MÁ, Fernández-Rodríguez A. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg Microbes Infect 2022;:1-68. [PMID: 35130828 DOI: 10.1080/22221751.2022.2038021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
13 Hasankhani A, Bahrami A, Sheybani N, Aria B, Hemati B, Fatehi F, Ghaem Maghami Farahani H, Javanmard G, Rezaee M, Kastelic JP, Barkema HW. Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic. Front Immunol 2021;12:789317. [PMID: 34975885 DOI: 10.3389/fimmu.2021.789317] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]